Clorox (NYSE:CLX) Given New $115.00 Price Target at Evercore ISI

Clorox (NYSE:CLX) had its price target reduced by Evercore ISI from $132.00 to $115.00 in a report issued on Wednesday morning, MarketBeat Ratings reports. They currently have an underperform rating on the stock.

Other equities analysts have also issued research reports about the stock. Jefferies Financial Group reiterated a “buy” rating and issued a $152.00 target price on shares of Clorox in a research report on Tuesday, November 4th. Zacks Research raised shares of Clorox from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $120.00 to $114.00 and set a “neutral” rating on the stock in a research note on Friday, January 16th. BNP Paribas Exane dropped their target price on Clorox from $103.00 to $101.00 and set an “underperform” rating on the stock in a report on Friday, January 16th. Finally, UBS Group decreased their price target on Clorox from $119.00 to $115.00 and set a “neutral” rating for the company in a research note on Wednesday, January 14th. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat, Clorox currently has an average rating of “Reduce” and an average target price of $117.00.

Clorox Stock Performance

Shares of CLX stock opened at $117.68 on Wednesday. Clorox has a 12-month low of $96.66 and a 12-month high of $159.04. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50. The firm has a market capitalization of $14.35 billion, a price-to-earnings ratio of 19.23, a price-to-earnings-growth ratio of 0.57 and a beta of 0.59. The business has a 50 day simple moving average of $105.39 and a 200 day simple moving average of $113.99.

Clorox (NYSE:CLX) last announced its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 299.67%. The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the firm earned $1.55 EPS. The firm’s revenue was down .8% on a year-over-year basis. On average, equities research analysts anticipate that Clorox will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.2%. The ex-dividend date is Wednesday, January 28th. Clorox’s dividend payout ratio is 77.86%.

Insider Activity

In related news, Director Pierre R. Breber bought 4,000 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The shares were acquired at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the acquisition, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. 0.63% of the stock is owned by insiders.

Hedge Funds Weigh In On Clorox

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Savvy Advisors Inc. raised its holdings in shares of Clorox by 1.4% in the second quarter. Savvy Advisors Inc. now owns 6,395 shares of the company’s stock valued at $768,000 after purchasing an additional 91 shares during the last quarter. Canandaigua National Bank & Trust Co. grew its position in Clorox by 0.8% in the 3rd quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock worth $1,380,000 after purchasing an additional 94 shares in the last quarter. State of Michigan Retirement System increased its stake in Clorox by 0.3% in the 2nd quarter. State of Michigan Retirement System now owns 33,551 shares of the company’s stock valued at $4,028,000 after buying an additional 100 shares during the last quarter. Field & Main Bank lifted its position in shares of Clorox by 3.3% during the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after buying an additional 100 shares in the last quarter. Finally, Fisher Asset Management LLC lifted its position in shares of Clorox by 1.7% during the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock worth $746,000 after buying an additional 102 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Trending Headlines about Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Revenue slightly beat consensus — Q2 revenue came in at about $1.67B, a small beat versus Street estimates, which helps offset some concerns about profitability. Q2 Results Press Release
• Positive Sentiment: Some analysts still see significant upside — Jefferies retains a “buy” rating with a $151 target, signaling that at least part of Wall Street believes longer-term upside remains. Jefferies PT Article
• Neutral Sentiment: Management will present at the CAGNY conference on Feb. 19 — provides an opportunity for management to address questions about margin recovery, inventory and integration progress (potentially market-moving if new color is provided). CAGNY Presentation Notice
• Neutral Sentiment: Mixed small analyst adjustments — JPMorgan nudged its target slightly higher to $117 (neutral), signaling little change in near-term consensus. JPMorgan PT Article
• Negative Sentiment: EPS missed expectations and declined year‑over‑year — adjusted EPS of $1.39 missed consensus (~$1.43) and is down from a year ago, which pressured sentiment. Reuters Earnings Coverage
• Negative Sentiment: Margin headwinds persist — management cited higher costs, ERP/integration pressures and an inventory reset that could squeeze near‑term profits; several outlets flagged margin pressure and a profit squeeze outlook for 2026. Benzinga Profit Squeeze
• Negative Sentiment: Analyst downgrades/price‑target cuts on balance — Evercore cut its PT to $115 (underperform) and Deutsche Bank trimmed its PT to $112 (hold), adding downside risk near current levels. Evercore PT Article Deutsche Bank PT Article

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.